Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nature Communications|January 9, 2021
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative RhabdomyosarcomaSilvia Pomella, Prethish Sreenivas, Berkley E Gryder, et al.
Science Translational Medicine|July 6, 2018
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcomaMarielle E Yohe, Berkley E Gryder, Jack F Shern, et al.
Cancer Discovery|April 28, 2017
PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain VulnerabilityBerkley E Gryder, Marielle E Yohe, Hsien-Chao Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2022
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology GroupDavid Milewski, Hyun Jung, G Thomas Brown, et al.
Cancer Cell|January 1, 2019
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene RegulationSerap Erkek, Pascal D Johann, Martina A Finetti, et al.
Cell Reports. Medicine|July 14, 2026
Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancersMeijie Tian, Katrina Jia, Jerry T Wu, et al.
Blood Advances|January 6, 2023
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemiaKatherine E Masih, Rebecca A Gardner, Hsien-Chao Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2020
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor HomoharringtonineThomas P Howard, Elaine M Oberlick, Matthew G Rees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Cell Reports. Medicine|September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.
Pageof 4